1
The Vaccine Life Cycle safety at every phase GUIDE ACIP ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES BLA BIOLOGICS LICENSE APPLICATION CDC CENTERS FOR DISEASE CONTROL AND PREVENTION FDA FOOD AND DRUG ADMINISTRATION IND INVESTIGATIONAL NEW DRUG APPLICATION VACCINE DEVELOPMENT safety is a priority during vaccine development + approval BASIC RESEARCH DISCOVERY PRE- CLINICAL STUDIES ND I SUBMITTED CLINICAL STUDIES / TRIALS PHASE 1 safety PHASE 2 effectiveness PHASE 3 safety + effectiveness SUBMITTED BLA FDA REVIEW DA F AL APPROV CCINE EW VA N OF 1 ACIP REVIEW TION OMMENDA REC CIP A safety continues with CDC + FDA safety monitoring PHASE 4 safety monitoring for serious, unexpected adverse events POST-APPROVAL MONITORING + RESEARCH LEARN MORE FDA VACCINE DEVELOPMENT + APPROVAL PROCESS http://go.usa.gov/xvvNd CDC VACCINE SAFETY MONITORING + RESEARCH http://go.usa.gov/xvvNe

The Vaccine Life CycleThe Vaccine Life Cycle safety at every phase GUIDE ACIP ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES BLA BIOLOGICS LICENSE APPLICATION . CDC . CENTERS FOR DISEASE

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: The Vaccine Life CycleThe Vaccine Life Cycle safety at every phase GUIDE ACIP ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES BLA BIOLOGICS LICENSE APPLICATION . CDC . CENTERS FOR DISEASE

The Vaccine Life Cycle safety at every phase

GUIDE

ACIP ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES

BLA BIOLOGICS LICENSE APPLICATION

CDC CENTERS FOR DISEASE CONTROL AND PREVENTION

FDA FOOD AND DRUG ADMINISTRATION

IND INVESTIGATIONALNEW DRUG APPLICATION

VACC INE DEVELOPMENT

safety is a priority

during vaccine development

+ approval

BASIC RESEARCH

DISCOVERY PRE-CLINICAL

STUDIES

ND

I

SUB

MIT

TED

CLINICAL STUDIES / TRIALS

PHASE 1 safety

PHASE 2

effectiveness

PHASE 3

safety + effectiveness

SU

BM

ITTE

D

BLA

FDA REVIEW

D

AF

AL

APP

RO

V

CC

INE

EW V

A N

OF

1

ACIP REVIEW

TIO

N

OM

MEN

DA

REC

CIP

A

safety continues with

CDC + FDA safety

monitoring

PHASE 4

safety monitoring for serious, unexpected

adverse events

POST-APPROVAL MONITORING + RESEARCH

LEARN MORE

FDA VACCINE DEVELOPMENT + APPROVAL PROCESS http://go.usa.gov/xvvNdCDC VACCINE SAFETY MONITORING + RESEARCH http://go.usa.gov/xvvNe